This inventor holds 5 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: University of Michigan, Mekanistic Therapeutics LLC, Warner-Lambert Company. Active years: 2002-2023.
Company Filing History:
3 out of 3,523 
1 out of 1 
1 out of 2,538 Years Active: 2002-2023
Title: Judith S. Leopold: Innovator in Medicinal Chemistry
Introduction
Judith S. Leopold is a prominent inventor based in Ann Arbor, MI (US). She has made significant contributions to the field of medicinal chemistry, particularly in the development of small-molecule inhibitors for cancer treatment. With a total of 5 patents to her name, her work has the potential to impact therapeutic approaches for various diseases.
Latest Patents
One of her latest patents is titled "Substituted aminobenzyl heteroaryl compounds as EGFR and/or PI3K inhibitors." This invention relates to a new class of small molecules that function as dual inhibitors of EGFR and PI3K proteins. These compounds are designed to serve as therapeutics for diseases mediated by these proteins, including cancer. Another notable patent is "Small molecule inhibitors of EGFR and PI3K," which focuses on small molecules with a quinazoline or quinoline structure that also act as dual inhibitors. This invention further emphasizes her commitment to advancing cancer treatment options.
Career Highlights
Judith has worked with esteemed organizations such as the University of Michigan and Warner-Lambert Company. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Throughout her career, Judith has collaborated with notable colleagues, including Christopher Whitehead and Roger Schofield Newton. These partnerships have enriched her research and expanded the impact of her inventions.
Conclusion
Judith S. Leopold stands out as an influential inventor in medicinal chemistry, with her innovative patents paving the way for new therapeutic strategies against cancer. Her dedication to research and collaboration continues to inspire advancements in the field.